Thomas Catinazzo - Sep 13, 2021 Form 4 Insider Report for Relay Therapeutics, Inc. (RLAY)

Role
Senior Vice President, Finance
Signature
/s/ Brian Adams, as Attorney-in-Fact
Stock symbol
RLAY
Transactions as of
Sep 13, 2021
Transactions value $
-$694,800
Form type
4
Date filed
9/13/2021, 08:24 PM
Previous filing
Jun 30, 2021
Next filing
Sep 27, 2021

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction RLAY Common Stock Options Exercise $92.7K +22.5K +144.44% $4.12 38.1K Sep 13, 2021 Direct F1
transaction RLAY Common Stock Sale -$788K -22.5K -59.09% $35.00 15.6K Sep 13, 2021 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction RLAY Stock Option (Right to Buy) Options Exercise $0 -22.5K -26.61% $0.00 62K Sep 13, 2021 Common Stock 22.5K $4.12 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The reported transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 17, 2020.
F2 Twenty-five percent (25%) of the shares underlying this option vested on April 9, 2019 and the remainder shall vest in equal quarterly installments over the remaining thirty-six (36) months, subject to the reporting person's continued employment through each vesting date.